EGM
CGEM icon

Engineers Gate Manager’s Cullinan Oncology CGEM Stock Holding History

Engineers Gate Manager’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
153,050
+86,762
+131% +$1.29M 0.04% 554
2026
Q1 		$942K Sell
66,288
-3,055
-4% -$39.3K 0.01% 1081
2025
Q4 		$718K Buy
69,343
+18,980
+38% +$171K 0.01% 1195
2025
Q3 		$299K Buy
50,363
+32,239
+178% +$236K ﹤0.01% 1743
2025
Q2 		$136K Buy
+18,124
New +$146K ﹤0.01% 1955
2024
Q4 		– Sell
-12,245
Closed -$205K – 2263
2024
Q3 		$205K Buy
+12,245
New +$217K ﹤0.01% 1792

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Engineers Gate Manager's CGEM Position: Q2 2026 in Review

Engineers Gate Manager increased its Cullinan Oncology (CGEM) stake by 131% in Q2 2026, buying an estimated $1.29M and bringing the position to 153,050 shares worth $2.79M. The position accounts for 0.04% of the portfolio, ranked #554.

Engineers Gate Manager first reported a position in CGEM in Q3 2024 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Engineers Gate Manager held 153,050 shares of Cullinan Oncology worth $2.79M as of Q2 2026.
  • Engineers Gate Manager bought 86,762 Cullinan Oncology shares in Q2 2026, an estimated $1.29M.
  • Cullinan Oncology made up 0.04% of Engineers Gate Manager's portfolio in Q2 2026, its #554 holding.
  • Engineers Gate Manager first reported a position in Cullinan Oncology in Q3 2024 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.